Literature DB >> 1812360

Susceptibility contrast imaging of cerebral blood volume: human experience.

B R Rosen1, J W Belliveau, H J Aronen, D Kennedy, B R Buchbinder, A Fischman, M Gruber, J Glas, R M Weisskoff, M S Cohen.   

Abstract

Magnetic resonance (MR) can offer a unique window on the structure/function relationships in the brain, by utilizing the established link between tissue function, metabolism, and hemodynamics. This report focuses on recent applications of MR-based cerebral blood volume (CBV) imaging in humans. Our methodology uses high-speed "single-shot" or echo planar imaging techniques, which provide the necessary temporal resolution for mapping the rapid cerebral transit of contrast agents. These MR CBV mapping techniques have been used to study normal human brain task activation and in the clinical study of patients with brain tumors. In the latter, positron emission tomography imaging was used for functional metabolic and CBV correlation. Susceptibility contrast CBV imaging should allow us to improve our understanding of the relationship between the detailed physiology and morphology of the microvascular bed and functional attributes of the brain. These techniques can be applied to understanding fundamental questions of cognitive neuroscience and can aid in improving diagnostic sensitivity and specificity in various neuropathologies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1812360     DOI: 10.1002/mrm.1910220227

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  41 in total

Review 1.  The neural basis of the blood-oxygen-level-dependent functional magnetic resonance imaging signal.

Authors:  Nikos K Logothetis
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-08-29       Impact factor: 6.237

Review 2.  Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR Imaging.

Authors:  James R Fink; Mark Muzi; Melinda Peck; Kenneth A Krohn
Journal:  J Nucl Med       Date:  2015-08-20       Impact factor: 10.057

3.  Mapping the dynamics of brain perfusion using functional ultrasound in a rat model of transient middle cerebral artery occlusion.

Authors:  Clément Brunner; Clothilde Isabel; Abraham Martin; Clara Dussaux; Anne Savoye; Julius Emmrich; Gabriel Montaldo; Jean-Louis Mas; Jean-Claude Baron; Alan Urban
Journal:  J Cereb Blood Flow Metab       Date:  2015-12-31       Impact factor: 6.200

4.  Acute dural venous sinus thrombosis without brain parenchymal abnormality: assessment with cerebral blood volume using dynamic susceptibility contrast magnetic resonance imaging.

Authors:  Kyo Noguchi; Hideo Hamada; Michiya Kubo; Masashi Shimizu; Hikaru Seto
Journal:  Radiat Med       Date:  2006-11-24

5.  A novel technique for modeling susceptibility-based contrast mechanisms for arbitrary microvascular geometries: the finite perturber method.

Authors:  Arvind P Pathak; B Douglas Ward; Kathleen M Schmainda
Journal:  Neuroimage       Date:  2008-01-29       Impact factor: 6.556

6.  Quantification of cerebral perfusion using the "bookend technique": an evaluation in CNS tumors.

Authors:  Timothy J Carroll; Sandra Horowitz; Wanyong Shin; Jessy Mouannes; Rahul Sawlani; Saad Ali; Jeffrey Raizer; Stephen Futterer
Journal:  Magn Reson Imaging       Date:  2008-06-05       Impact factor: 2.546

Review 7.  Transverse NMR relaxation in biological tissues.

Authors:  Valerij G Kiselev; Dmitry S Novikov
Journal:  Neuroimage       Date:  2018-06-07       Impact factor: 6.556

Review 8.  Ultra-high-speed MR imaging.

Authors:  C P Davis; G C McKinnon; J F Debatin; G K von Schulthess
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

Review 9.  The promise of dynamic contrast-enhanced imaging in radiation therapy.

Authors:  Yue Cao
Journal:  Semin Radiat Oncol       Date:  2011-04       Impact factor: 5.934

10.  Perfusion MR imaging in gliomas: comparison with histologic tumor grade.

Authors:  S J Lee; J H Kim; Y M Kim; G K Lee; E J Lee; I S Park; J M Jung; K H Kang; T Shin
Journal:  Korean J Radiol       Date:  2001 Jan-Mar       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.